Mahoney David L
- SEC CIK
- 0001224091
In the past year, 2 open-market sale filings worth $13.9M and no purchases.
Current role at each company
- CORT Corcept Therapeutics IncDirectoras of Aug 20, 2026
- ADMS Adamas Pharmaceuticals IncDirectoras of Nov 24, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $13.9M
- 2 filings
- Net
- −$13.9M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Mahoney David L as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CORT Corcept Therapeutics Inc
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2023 (view filing) | Aug 14 | 2 days | Mahoney David LDirector | SSale | −25.0K | $30.95 | −$773.8K | −2.0%1.22M after | 2 lots10b5-1 |
| May 20, 2025 (view filing) | May 16 | 4 days | Mahoney David LDirector | SSale | −27.4K | $74.23 | −$2.03M | −100.0%0 after | 2 lots |
| Jun 18, 2026 (view filing) | Jun 17 | 1 day | Mahoney David LDirector | SSale | −20.0K | $84.53 | −$1.69M | −43.3%26.1K after | |
| Aug 20, 2026 (view filing)4:30 PM ET | Aug 18 | 2 days | Mahoney David LDirector | SSale | −103.6K | $118.25 | −$12.3M | −8.4%1.13M after | 4 lots10b5-1 |